Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis

Abstract

These data suggest that, according to the SASSAD score, ABT has beneficial effects in the treatment of AD, although this was not confirmed by the patient-rated assessments. The improvement in observer-rated skin condition suggested by this study needs confirmation in larger trials.